Position in ELAN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$81,561,360
+$34,516,125 QoQ
Shares Held
3,408,331
+63.9% QoQ
Ownership
0.682%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Capital World Investors holds $347,628,367 across 2 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,833,566 | $266,067,007 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
3,408,331 | $81,561,360 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,561,360 | 3,408,331 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $47,045,235 | 2,078,888 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $41,868,804 | 2,078,888 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,560,000 | 2,000,000 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||